Cardiosolutions, Inc. is a development stage company focused on a novel alternative to open heart surgery to solve the problem of mitral regurgitation.

Currently, we are developing a pioneering technology, the Mitra-Spacer ™ designed to deliver an implant that will provide a sealing surface for the leaflets of the mitral and/or tricuspid valve, thereby significantly reducing or eliminating valve regurgitation.

Our goal is to provide a new therapeutic alternative for a wide range of patients of all ages who suffer from moderate to severe mitral and/or tricuspid regurgitation, including a portion of those who are currently in congestive heart failure. Our less invasive procedure has the potential to substantially reduce procedure time, expedite patient recovery and provide a less costly alternative to current treatment options.

Caution – Investigational Device, Limited by Federal (or United States) Law to Investigational Use

Cardiosolutions, Inc. 375 West Street, West Bridgewater, MA 02379